Skip to main content
Premium Trial:

Request an Annual Quote

Michigan Taps Orchid Cellmark for Paternity Testing

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark will provide its DNA paternity testing services to the State of Michigan under a new contract valued at around $5.2 million, the company said today.

The firm said that the contract enables it to provide its services to the Michigan Department of Human Services' Office of Child Support and the Children's Protective Services.

The contract from the Michigan Department of Management and Budget makes the company the sole provider of all publicly funded DNA paternity tests in the state between April 2010 and March 2015, the company said.

In early Tuesday trade on the Nasdaq, shares of Orchid Cellmark were up 6 percent at $1.50.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.